| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Is Critical to the Control of Murine Autoimmune Encephalomyelitis and Regulates Both in the Periphery and in the Target Tissue: A Possible Role for Nitric Oxide1
*
Neurosciences Research Unit, Canberra Hospital, and
University of Sydney Canberra Clinical School, Canberra, Australian Capital Territory, Australia; and
John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia
NO and IFN-
have normally been considered cytotoxic and
proinflammatory molecules, respectively, in the setting of the central
nervous system inflammatory disease autoimmune encephalomyelitis (EAE).
Using mice lacking the ligand binding chain of the IFN- receptor
(IFNR-/-), we have previously shown that IFN- is
not essential for myelin oligodendrocyte glycoprotein peptide
(MOG35–55) induced EAE expression but is in fact essential
for its down-regulation. Here we examined the downstream molecular and
cellular mechanism(s) of IFN- regulation and demonstrate that
neither IL-4 nor IL-10 appear to play a role in down-regulation nor do
various lymphoid cell populations. Cells of the macrophage lineage are
key to down-regulation as evidenced by the fact that peritoneal exudate
cells from IFNR+/+ mice inhibit Ag-driven proliferation
of IFNR-/- lymphocytes, whereas
IFNR-/- peritoneal exudate cells do not. High levels
of reactive nitrogen intermediates are detected in the former cultures
but not the latter, and the inhibition of proliferation is reversible
with an inhibitor of inducible NO synthase, indicating a key role for
NO in down-regulation. Studies with bone marrow chimeras indicate that
down-regulation occurs not only systemically but also within the target
tissue. These data suggest that IFN- down-regulates EAE by inducing
inducible NO synthase and subsequently NO production, both by
macrophages in the periphery and, by inference, microglia and
astrocytes in the target tissue.
This article has been cited by other articles:
|
|
 |
|
  A. J. Canonigo-Balancio, C. Fos, T. Prod'homme, S. Becart, and A. Altman SLAT/Def6 Plays a Critical Role in the Development of Th17 Cell-Mediated Experimental Autoimmune Encephalomyelitis J. Immunol., December 1, 2009; 183(11): 7259 - 7267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Annunziato and S. Romagnani Do studies in humans better depict Th17 cells? Blood, September 10, 2009; 114(11): 2213 - 2219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fujita, T. Otsuka, M. Mizuno, C. Tomi, T. Yamamura, and S. Miyake Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Modulates Experimental Autoimmune Encephalomyelitis via an iNKT Cell-Dependent Mechanism Am. J. Pathol., September 1, 2009; 175(3): 1116 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Lees, Y. Iwakura, and J. H. Russell Host T Cells Are the Main Producers of IL-17 within the Central Nervous System during Initiation of Experimental Autoimmune Encephalomyelitis Induced by Adoptive Transfer of Th1 Cell Lines J. Immunol., June 15, 2008; 180(12): 8066 - 8072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mangalam, D. Luckey, E. Basal, M. Behrens, M. Rodriguez, and C. David HLA-DQ6 (DQB1*0601)-Restricted T Cells Protect against Experimental Autoimmune Encephalomyelitis in HLA-DR3.DQ6 Double-Transgenic Mice by Generating Anti-Inflammatory IFN-{gamma} J. Immunol., June 1, 2008; 180(11): 7747 - 7756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tian, J. Lappalainen, M. Autero, S. Hanninen, H. Rauvala, and C. G. Gahmberg Shedded neuronal ICAM-5 suppresses T-cell activation Blood, April 1, 2008; 111(7): 3615 - 3625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Balabanov, K. Strand, R. Goswami, E. McMahon, W. Begolka, S. D. Miller, and B. Popko Interferon-{gamma}-Oligodendrocyte Interactions in the Regulation of Experimental Autoimmune Encephalomyelitis J. Neurosci., February 21, 2007; 27(8): 2013 - 2024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Minguela, S. Pastor, W. Mi, J. A. Richardson, and E. S. Ward Feedback Regulation of Murine Autoimmunity via Dominant Anti-Inflammatory Effects of Interferon {gamma} J. Immunol., January 1, 2007; 178(1): 134 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Mana, D. Linares, S. Fordham, M. Staykova, and D. Willenborg Deleterious Role of IFN{gamma} in a Toxic Model of Central Nervous System Demyelination Am. J. Pathol., May 1, 2006; 168(5): 1464 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Liu, D. Huang, M. Matsui, T. T. He, T. Hu, J. DeMartino, B. Lu, C. Gerard, and R. M. Ransohoff Severe Disease, Unaltered Leukocyte Migration, and Reduced IFN-{gamma} Production in CXCR3-/- Mice with Experimental Autoimmune Encephalomyelitis J. Immunol., April 1, 2006; 176(7): 4399 - 4409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dawes, S. Petrova, Z. Liu, D. Wraith, P. C. L. Beverley, and E. Z. Tchilian Combinations of CD45 Isoforms Are Crucial for Immune Function and Disease J. Immunol., March 15, 2006; 176(6): 3417 - 3425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen and C. F. Brosnan Exacerbation of Experimental Autoimmune Encephalomyelitis in P2X7R-/- Mice: Evidence for Loss of Apoptotic Activity in Lymphocytes. J. Immunol., March 1, 2006; 176(5): 3115 - 3126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Galazka, M. Stasiolek, A. Walczak, A. Jurewicz, A. Zylicz, C. F. Brosnan, C. S. Raine, and K. W. Selmaj Brain-Derived Heat Shock Protein 70-Peptide Complexes Induce NK Cell-Dependent Tolerance to Experimental Autoimmune Encephalomyelitis J. Immunol., February 1, 2006; 176(3): 1588 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Sercan, G. J. Hammerling, B. Arnold, and T. Schuler Cutting Edge: Innate Immune Cells Contribute to the IFN-{gamma}-Dependent Regulation of Antigen-Specific CD8+ T Cell Homeostasis J. Immunol., January 15, 2006; 176(2): 735 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Hsieh Effects of Ultrasound and Diclofenac Phonophoresis on Inflammatory Pain Relief: Suppression of Inducible Nitric Oxide Synthase in Arthritic Rats Physical Therapy, January 1, 2006; 86(1): 39 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Zehntner, C. Brickman, L. Bourbonniere, L. Remington, M. Caruso, and T. Owens Neutrophils That Infiltrate the Central Nervous System Regulate T Cell Responses J. Immunol., April 15, 2005; 174(8): 5124 - 5131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Mekala, R. S. Alli, and T. L. Geiger IL-10-Dependent Suppression of Experimental Allergic Encephalomyelitis by Th2-Differentiated, Anti-TCR Redirected T Lymphocytes J. Immunol., March 15, 2005; 174(6): 3789 - 3797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Wensky, G. C. Furtado, M. C. Garibaldi Marcondes, S. Chen, D. Manfra, S. A. Lira, D. Zagzag, and J. J. Lafaille IFN-{gamma} Determines Distinct Clinical Outcomes in Autoimmune Encephalomyelitis J. Immunol., February 1, 2005; 174(3): 1416 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bettelli and V. K. Kuchroo IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together J. Exp. Med., January 18, 2005; 201(2): 169 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Staykova, J. T. Paridaen, W. B. Cowden, and D. O. Willenborg Nitric Oxide Contributes to Resistance of the Brown Norway Rat to Experimental Autoimmune Encephalomyelitis Am. J. Pathol., January 1, 2005; 166(1): 147 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Abromson-Leeman, R. Bronson, Y. Luo, M. Berman, R. Leeman, J. Leeman, and M. Dorf T-Cell Properties Determine Disease Site, Clinical Presentation, and Cellular Pathology of Experimental Autoimmune Encephalomyelitis Am. J. Pathol., November 1, 2004; 165(5): 1519 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Ponomarev, M. Novikova, M. Yassai, M. Szczepanik, J. Gorski, and B. N. Dittel {gamma}{delta} T Cell Regulation of IFN-{gamma} Production by Central Nervous System-Infiltrating Encephalitogenic T Cells: Correlation with Recovery from Experimental Autoimmune Encephalomyelitis J. Immunol., August 1, 2004; 173(3): 1587 - 1595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bettelli, B. Sullivan, S. J. Szabo, R. A. Sobel, L. H. Glimcher, and V. K. Kuchroo Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis J. Exp. Med., July 6, 2004; 200(1): 79 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-G. Xiao, X.-C. Wu, J.-S. Yang, L.-Y. Xu, X. Liu, Y.-M. Huang, B. Bjelke, and H. Link Therapeutic potential of IFN-{gamma}-modified dendritic cells in acute and chronic experimental allergic encephalomyelitis Int. Immunol., January 1, 2004; 16(1): 13 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Gran, G.-X. Zhang, S. Yu, J. Li, X.-H. Chen, E. S. Ventura, M. Kamoun, and A. Rostami IL-12p35-Deficient Mice Are Susceptible to Experimental Autoimmune Encephalomyelitis: Evidence for Redundancy in the IL-12 System in the Induction of Central Nervous System Autoimmune Demyelination J. Immunol., December 15, 2002; 169(12): 7104 - 7110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G-X Zhang, M Kishi, H Xu, and A Rostami Mature bone marrow-derived dendritic cells polarize Th2 response and suppress experimental autoimmune encephalomyelitis Multiple Sclerosis, December 1, 2002; 8(6): 463 - 468. [Abstract] [PDF]
|
|
|
|
|
|
K. Nicolson, S. Freland, C. Weir, B. Delahunt, R. A. Flavell, and B. T. Backstrom Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2 Int. Immunol., August 1, 2002; 14(8): 849 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Marchetti, M. C. Morale, J. Brouwer, C. Tirolo, N. Testa, S. Caniglia, N. Barden, S. Amor, P. A. Smith, and C. D. Dijkstra Exposure to a Dysfunctional Glucocorticoid Receptor from Early Embryonic Life Programs the Resistance to Experimental Autoimmune Encephalomyelitis Via Nitric Oxide-Induced Immunosuppression J. Immunol., June 1, 2002; 168(11): 5848 - 5859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-G. Yang, J. Qi, M.-G. Wang, and M. Sykes Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells Blood, May 13, 2002; 99(11): 4207 - 4215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-X. Zhang, H. Xu, M. Kishi, D. Calida, and A. Rostami The Role of IL-12 in the Induction of Intravenous Tolerance in Experimental Autoimmune Encephalomyelitis J. Immunol., March 1, 2002; 168(5): 2501 - 2507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Arnett, R. P. Hellendall, G. K. Matsushima, K. Suzuki, V. E. Laubach, P. Sherman, and J. P.-Y. Ting The Protective Role of Nitric Oxide in a Neurotoxicant- Induced Demyelinating Model J. Immunol., January 1, 2002; 168(1): 427 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Brand, L. K. Myers, K. B. Whittington, K. A. Latham, J. M. Stuart, A. H. Kang, and E. F. Rosloniec Detection of Early Changes in Autoimmune T Cell Phenotype and Function Following Intravenous Administration of Type II Collagen in a TCR-Transgenic Model J. Immunol., January 1, 2002; 168(1): 490 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Liu, Y. Yu, M. Zhang, W. Wang, and X. Cao The Involvement of TNF-{{alpha}}-Related Apoptosis-Inducing Ligand in the Enhanced Cytotoxicity of IFN-{{beta}}-Stimulated Human Dendritic Cells to Tumor Cells J. Immunol., May 1, 2001; 166(9): 5407 - 5415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-Y. Xu, J.-S. Yang, H. Link, and B.-G. Xiao SIN-1, a Nitric Oxide Donor, Ameliorates Experimental Allergic Encephalomyelitis in Lewis Rats in the Incipient Phase: The Importance of the Time Window J. Immunol., May 1, 2001; 166(9): 5810 - 5816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Juedes and N. H. Ruddle Resident and Infiltrating Central Nervous System APCs Regulate the Emergence and Resolution of Experimental Autoimmune Encephalomyelitis J. Immunol., April 15, 2001; 166(8): 5168 - 5175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Grohmann, F. Fallarino, S. Silla, R. Bianchi, M. L. Belladonna, C. Vacca, A. Micheletti, M. C. Fioretti, and P. Puccetti CD40 Ligation Ablates the Tolerogenic Potential of Lymphoid Dendritic Cells J. Immunol., January 1, 2001; 166(1): 277 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Weishaupt, S. Jander, W. Bruck, T. Kuhlmann, M. Stienekemeier, T. Hartung, K. V. Toyka, G. Stoll, and R. Gold Molecular Mechanisms of High-Dose Antigen Therapy in Experimental Autoimmune Encephalomyelitis: Rapid Induction of Th1-Type Cytokines and Inducible Nitric Oxide Synthase J. Immunol., December 15, 2000; 165(12): 7157 - 7163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Cauley, E. E. Miller, M. Yen, and S. L. Swain Superantigen-Induced CD4 T Cell Tolerance Mediated by Myeloid Cells and IFN-{gamma} J. Immunol., December 1, 2000; 165(11): 6056 - 6066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Matthys, K. Vermeire, H. Heremans, and A. Billiau The protective effect of IFN-{gamma} in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis J. Leukoc. Biol., October 1, 2000; 68(4): 447 - 454. [Abstract] [Full Text]
|
|
|
|
|
|
U. Grohmann, R. Bianchi, M. L. Belladonna, S. Silla, F. Fallarino, M. C. Fioretti, and P. Puccetti IFN-{gamma} Inhibits Presentation of a Tumor/Self Peptide by CD8{alpha}- Dendritic Cells Via Potentiation of the CD8{alpha}+ Subset J. Immunol., August 1, 2000; 165(3): 1357 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-Q. Chu, S. Wittmer, and D. K. Dalton Failure to Suppress the Expansion of the Activated Cd4 T Cell Population in Interferon {gamma}-Deficient Mice Leads to Exacerbation of Experimental Autoimmune Encephalomyelitis J. Exp. Med., July 3, 2000; 192(1): 123 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Vermeire, L. Thielemans, P. Matthys, and A. Billiau The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-{gamma} J. Leukoc. Biol., July 1, 2000; 68(1): 119 - 124. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
